Mesothelioma review.
Malignant mesothelioma (MME) is an aggressive tumor of serosal surfaces resistant to current treatment options. MME is typically diagnosed in middle aged males exposed to asbestos in the workplace. However, MME is occasionally diagnosed at an earlier age without an obvious source of exposure. MME typically carries an average survival rate of six to thirteen months. A new treatment option, the trimodality approach, has recently been proclaimed as superior to standard treatment. Therefore, a case of a 38-year-old-female diagnosed with MME is reported to review its epidemiology, pathogenesis, clinical presentation, diagnostic modalities and most current treatment options.
Montjoy
Carol
C
Department of Pulmonary and Critical Care Medicine, West Virginia University Hospital, USA.
Parker
John
J
Petsonk
Lee
L
Luis
Teba
T
Fallon
Kenneth
K
D000328:Adult; D000367:Age Factors; D001194:Asbestos / Q000633:toxicity; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D008297:Male; D008654:Mesothelioma / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D009362:Neoplasm Metastasis; D011379:Prognosis; D012307:Risk Factors; D017678:Sex Distribution
D001194:Asbestos